6,541 followers
New research: Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy: Background Atezolizumab is superior to… https://t.co/umFg